Cryptococcal antigen screening and preemptive therapy in patients initiating antiretroviral therapy in resource-limited settings: A proposed algorithm for clinical implementation

Journal of the International Association of Physicians in AIDS Care

Volumn 11, Issue 6, 2012, Pages 374-379

  Jarvis, Joseph N ^a   Govender, Nelesh ^b   Chiller, Tom ^c   Park, Benjamin J ^c   Longley, Nicky ^a,d   Meintjes, Graeme ^d,e   Bekker, Linda Gail ^d   Wood, Robin ^d   Lawn, Stephen D ^d,f   Harrison, Thomas S ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

cryptococcal antigen; cryptococcal meningitis; prevention; screening

Indexed keywords

ANTIGEN; FLUCONAZOLE;

ALGORITHM; CD4 LYMPHOCYTE COUNT; CRYPTOCOCCAL ANTIGEN IMMUNOASSAY; CRYPTOCOCCAL MENINGITIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; LUMBAR PUNCTURE; PRIORITY JOURNAL; REVIEW;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ALGORITHMS; ANTI-HIV AGENTS; ANTIFUNGAL AGENTS; ANTIGENS, FUNGAL; CD4 LYMPHOCYTE COUNT; CRYPTOCOCCUS NEOFORMANS; DEVELOPING COUNTRIES; EARLY DIAGNOSIS; FLUCONAZOLE; HIV INFECTIONS; HUMANS; MENINGITIS, CRYPTOCOCCAL; SOUTH AFRICA; SPINAL PUNCTURE; TIME FACTORS;

EID: 84869066608     PISSN: 15451097     EISSN: 15570886     Source Type: Journal    
DOI: 10.1177/1545109712459077     Document Type: Review

References (38)

1. Lawn S, Harries A, Anglaret X, Myer L, Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS. 2008 ; 22 (15). 1897-1908
2. Harling G, Orrell C, Wood R. Healthcare utilization of patients accessing an African national treatment program. BMC Health Serv Res. 2007 ; 7: 80
3. Jarvis JN, Meintjes G, Harrison TS. Outcomes of cryptococcal meningitis in antiretroviral naive and experienced patients in South Africa. J Infect. 2010 ; 60 (6). 496-498
4. Jarvis JN, Lawn SD, Wood R, Harrison TS. Cryptococcal antigen screening for patients initiating antiretroviral therapy: time for action. Clin Infect Dis. 2010 ; 51 (12). 1463-1465
5. Jarvis JN, Harrison TS, Govender N, et al. Routine cryptococcal antigen screening for HIV-infected patients with low CD4+ T-lymphocyte counts: time to implement in South Africa?. S Afr Med J. 2011 ; 101 (4). 232-234
6. Meya DB, Manabe YC, Castelnuovo B, et al. Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings. Clin Infect Dis. 2010 ; 51 (4). 448-455
7. Micol R, Tajahmady A, Lortholary O, et al. Cost-effectiveness of primary prophylaxis of AIDS associated cryptococcosis in Cambodia. PLoS One. 2010 ; 5 (11). e13856
8. Parkes-Ratanshi R, Wakeham K, Levin J, et al. Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial. Lancet Infect Dis. 2011 ; 11 (2). 933-941
9. Jarvis JN, Lawn SD, Vogt M, Bangani N, Wood R, Harrison TS. Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa. Clin Infect Dis. 2009 ; 48 (7). 856-862
10. Bicanic T, Meintjes G, Wood R, et al. Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole. Clin Infect Dis. 2007 ; 45 (1). 76-80
11. French N, Gray K, Watera C, et al. Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults. AIDS. 2002 ; 16 (7). 1031-1038
12. Lara-Peredo O, Cuevas LE, French N, Bailey JW, Smith DH. Cryptococcal infection in an HIV-positive Ugandan population. J Infect. 2000 ; 41 (2). 195
13. Desmet P, Kayembe KD, De Vroey C.. The value of cryptococcal serum antigen screening among HIV-positive/AIDS patients in Kinshasa, Zaire. AIDS. 1989 ; 3 (2). 77-78
14. Tassie JM, Pepper L, Fogg C, et al. Systematic screening of cryptococcal antigenemia in HIV-positive adults in Uganda. J Acquir Immune Defic Syndr. 2003 ; 33 (3). 411-412
15. Liechty CA, Solberg P, Were W, et al. Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda. Trop Med Int Health. 2007 ; 12 (8). 929-935
16. Micol R, Lortholary O, Sar B, et al. Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients. J Acquir Immune Defic Syndr. 2007 ; 45 (5). 555-559
17. Pongsai P, Atamasirikul K, Sungkanuparph S. The role of serum cryptococcal antigen screening for the early diagnosis of cryptococcosis in HIV-infected patients with different ranges of CD4 cell counts. J Infect. 2010 ; 60 (6). 474-477
18. Apisarnthanarak A, Mundy LM. The impact of primary prophylaxis for cryptococcosis on fluconazole resistance in Candida species. J Acquir Immune Defic Syndr. 2008 ; 47 (5). 644-645
19. Jarvis JN, Percival A, Bauman S, et al. Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis. Clin Infect Dis. 2011 ; 53 (10). 1019-1023
20. Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis. 2010 ; 50 (3). 291-322
21. Feldmesser M, Harris C, Reichberg S, Khan S, Casadevall A. Serum cryptococcal antigen in patients with AIDS. Clin Infect Dis. 1996 ; 23 (4). 827-830
22. Yuen C, Graziani A, Pietroski N, Macgregor R, Schuster M. Cryptococcal antigenemia in HIV-infected patients [abstract no. 93]. Clin Infect Dis. 1994 ; 19: 579
23. Chang LW, Phipps WT, Kennedy GE, Rutherford GW.. Antifungal interventions for the primary prevention of cryptococcal disease in adults with HIV. Cochrane Database Syst Rev. 2005 ; (3). CD004773
24. Longley N, Muzoora C, Taseera K, et al. Dose response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda. Clin Infect Dis. 2008 ; 47 (12). 1556-1561
25. Milefchik E, Leal M, Haubrich R, et al 4th CROI. 1997. Washington, DC: ; 1997:
26. Rex JH, Pappas PG, Karchmer AW, et al. A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects. Clin Infect Dis. 2003 ; 36 (10). 1221-1228
27. Pappas PG, Chetchotisakd P, Larsen RA, et al. A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis. Clin Infect Dis. 2009 ; 48 (12). 1775-1783
28. Guidelines for the Prevention, Diagnosis and Management of Cryptococcal Meningitis and Disseminated Cryptococcosis in HIV-infected Patients. South Afr J HIV Med. 2007 ; 28: 25-35
29. Makadzange AT, Ndhlovu CE, Takarinda K, et al. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa. Clin Infect Dis. 2010 ; 50 (11). 1532-1538
30. Zolopa A, Andersen J, Powderly W, et al. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS One. 2009 ; 4 (5). e5575
31. 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention. Odhiambo N Kendi C Meyer AC, ed. Italy: Rome ; 2011:
32. 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention. Kendi C Penner J Otieno B, ed. Italy: Rome ; 2011:
33. National Department of Health (SA). South African national strategic plan for HIV, STI's and TB 2012-2016. NDoH 2011, http://www.doh.gov.za/list.php? type=StrategicDocuments
34. WHO. Rapid advice: diagnosis, prevention and management of cryptococcal Disease in HIV-infected adults, adolescents and children. December 2011.
35. Nayak SU, Talwani R, Gilliam B, Taylor G, Ghosh M. Cryptococcal Meningitis in an HIV-positive pregnant woman. J Int Assoc Physicians AIDS Care (Chic). 2011 ; 10 (2). 79-82
36. Norgaard M, Pedersen L, Gislum M, et al. Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study. J Antimicrob Chemother. 2008 ; 62 (1). 172-176
37. Lindsley MD, Mekha N, Baggett HC, et al. Evaluation of a newly developed lateral flow immunoassay for the diagnosis of cryptococcosis. Clin Infect Dis. 2011 ; 53 (4). 321-325
38. 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention. Jarvis JN Harrison TS Lawn SD Meintjes G Wood R Cleary S, ed. Italy: Rome ; 2011: